Population
52,555 patients who underwent major colorectal surgery between 2005-2008 from the National Surgical Quality…
Design
Cohort
Follow-up
30 days
Authors
Loading...
Supports targeted extended prophylaxis in high-risk colorectal patients; leaves open efficacy pending randomized trials.
The incidence of postdischarge symptomatic VTE after major colorectal surgery is 0.67%, and specific risk factors can help identify patients who may benefit from prolonged prophylaxis.
Fleming et al. (2010) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: